TAP
24
-5
AIV
37
4
MCO
68
-2
ROP
32
-3
AAL
38
-3
ED
52
3
KMB
22
2
COP
53
8
MUR
45
5
HRB
42
5
EMC
63
-2
A
51
-3
UHS
56
2
EL
67
11
RCL
74
-2
CCL
82
-3
GPC
61
7
TJX
55
7
EIX
43
3
BRK.B
43
5
TAP
24
-5
AIV
37
4
MCO
68
-2
ROP
32
-3
AAL
38
-3
ED
52
3
KMB
22
2
COP
53
8
MUR
45
5
HRB
42
5
EMC
63
-2
A
51
-3
UHS
56
2
EL
67
11
RCL
74
-2
CCL
82
-3
GPC
61
7
TJX
55
7
EIX
43
3
BRK.B
43
5
Financhill
Back

Esquire Financial Holdings, Inc. Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison

Buy
76

ESQ
Esquire Financial Holdings, Inc.

Last Price:
$108.23
Seasonality Move:
-1%
Sell
34

CRNX
Crinetics Pharmaceuticals, Inc.

Last Price:
$53.24
Seasonality Move:
-11.9%
Buy
76
Esquire Financial Holdings, Inc. (ESQ) is a Buy

Is Esquire Financial Holdings, Inc. a Buy, Sell or Hold?

  • The current Esquire Financial Holdings, Inc. [ESQ] share price is $110.73. The Score for ESQ is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
  • ESQ is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.24. The Score for CRNX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ESQ Stock Price Chart

What is Esquire Financial Holdings, Inc.'s stock price today?

  • The Esquire Financial Holdings, Inc. share price today is $110.73
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ESQ is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals, Inc.'s stock price today?

  • The Crinetics Pharmaceuticals, Inc. share price today is $53.24
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing slight selling pressure.

ESQ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.25 Buy
Relative Strength Index (14 RSI): 67.2 Buy
Chaikin Money Flow: 39286 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.47 - 107.65) Buy
Bollinger Bands (100): (97.11 - 104.89) Buy

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.28 Buy
Relative Strength Index (14 RSI): 65.68 Buy
Chaikin Money Flow: -209678 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.25 - 50.15) Buy
Bollinger Bands (100): (35.32 - 47.44) Buy

ESQ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 105.41 Buy
20-day SMA: 106.04 Buy
50-day SMA: 101.67 Buy
200-day SMA: 95.18 Buy
8-day EMA: 106.68 Buy
20-day EMA: 105.45 Buy
50-day EMA: 103.29 Buy
200-day EMA: 94.87 Buy

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.77 Buy
20-day SMA: 48.57 Buy
50-day SMA: 45.67 Buy
200-day SMA: 36.1 Buy
8-day EMA: 49.69 Buy
20-day EMA: 48.35 Buy
50-day EMA: 45.87 Buy
200-day EMA: 40.28 Buy

Esquire Financial Holdings, Inc. Earnings Growth & ESQ Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.64 per share, and an increase next year of $0.62 per share.

Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.

Esquire Financial Holdings, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):